In Conversation with COVID-19 Leaders 

Leah Rosenbaum – Assistant Editor, Healthcare & Science, Forbes

Jeremy Levin CEO, Ovid Therapeutics; Board of Directors Chair, Biotechnology Innovation Organization (BIO)

Michelle McMurry-Heath President and CEO, Biotechnology Innovation Organization (BIO)

Register online to watch Part 2.

Gain access to four
COVID-19 conversations

co-produced by: 

We made four COVID-19 related sessions open to the public. Watch them now!

All Rights Reserved. Forward ® 2021

EBD Group Inc., 3150 Pio Pico Drive, Suite 201, Carlsbad, CA, 92008

Part 1:

The world according to COVID-19: From crisis to long-term impact

The path forward 

Sara Jane Demy - CEO and Founder, Demy-Colton

Rick Bright - Former Director, Biomedical Advanced Research and Development Authority (BARDA), Transition Team, COVID-19 Advisory Board

COVID-19 therapeutics: A review of the options 
In the balance: The humanitarian perspective global policy

Jeremy Abbate, Publisher, Scientific American  

Ruxandra Draghia-Akli, Global Head, Johnson & Johnson Global Public Health R&D  

Amy Finan, CEO, Sabin Vaccine Institute 

Richard  Hatchett, CEO, CEPI 

Stephen G. Brozak, Managing Partner and President, WBB Securities LLC            

Prabhavathi Fernandes,Chair, National Biodefense Science Board 

Michael Kurilla, Director of Division of Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health